Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Longitudinal EEG Characteristics of Anti-GAD65 Antibody Related Autoimmune Epilepsy.
Journal: Clinical EEG and neuroscience
Published: May 14, 2025
Lack of association between generic brittleness and neuropsychiatric measures in patients with epilepsy.
Journal: Epilepsy & behavior : E&B
Published: October 31, 2021
Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy.
Journal: Pharmaceutical research
Published: November 01, 2019
Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy.
Journal: Epilepsy & behavior : E&B
Published: October 29, 2019
Exploring generic brittleness and the demographic factors for its susceptibility in patients with epilepsy.
Journal: Epilepsy & behavior : E&B
Published: October 10, 2018
Release of levetiracetam from extended-release tablets that appear intact in patient stool.
Journal: Seizure
Published: February 05, 2016
Reply to "On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs".
Journal: Journal of pharmaceutical sciences
Published: February 03, 2016
Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir.
Journal: Journal of pharmaceutical sciences
Published: July 15, 2015
Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
Journal: Epilepsia
Published: June 29, 2015
Biopharmaceutic Risk Assessment of Brand and Generic Lamotrigine Tablets.
Journal: Molecular pharmaceutics
Published: May 23, 2015
Anticonvulsant hypersensitivity syndrome: identification and management.
Journal: Current treatment options in neurology
Published: June 21, 2007
Showing 1-11 of 11
Last Updated: 09/26/2026